Načítá se...
Novel biomarkers for the detection of prostate cancer
Prostate-specific antigen (PSA) is widely used as a biomarker in the detection of prostate cancer and for decision making regarding treatment options, response to therapy, and clinical follow-up. Despite its widespread use, it is well recognised that PSA has suboptimal performance as a screening too...
Uloženo v:
| Vydáno v: | J Clin Urol |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publications
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5356177/ https://ncbi.nlm.nih.gov/pubmed/28344810 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2051415816656121 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|